Studies related to Lipid Peroxidation and Curcumin

Improvement In Oxidative Stress And Antioxidant Parameters In Beta-thalassemia/Hb E Patients Treated With Curcuminoids

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 21
Sex n/a
Age Range 30-44, 45-64
Notes for this study:
Curcuminoids, at three daily doses of 250mg, is associated with lessening the oxidative damage in beta-thalassemia/Hb E patients. Glutathione peroxidase and superoxide dismutase were both increased in the red blood cells of patients given curcumin.

Full details on all 7 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.